IP Library Granted Patent US 11,246,622
Granted Patent B2
US 11,246,622 · App. 16/549,834 · Granted Feb 15, 2022

Surgical instrument with staged application of electrosurgical and ultrasonic energy

Inventor: Kevin L. Houser (Springboro, OH)
Assignee: Cilag GmbH International
A61B17/320092A61B18/1445A61B18/1447A61B18/1492A61B2017/00389A61B2017/2946A61B2017/320094A61B2017/320095A61B2018/0063A61B2018/00202A61B2018/00404A61B2018/00595A61B2018/00601A61B2018/00607A61B2018/00619A61B2018/00642A61B2018/00654A61B2018/00666A61B2018/00708A61B2018/00815A61B2018/00875A61B2018/00922A61B2018/00994A61B2018/126A61B2018/1455
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 11,246,622
App. No.
16/549,834
Granted
Feb 15, 2022
Kind
B2
Abstract

An apparatus includes a body, a shaft assembly, an end effector, and a control module. The shaft assembly extends distally from the body and includes an acoustic waveguide. The waveguide is configured to acoustically couple with an ultrasonic transducer. The end effector includes an ultrasonic blade, a clamp arm, an electrode, and a sensor. The ultrasonic blade is in acoustic communication with the waveguide. The clamp arm is operable to compress tissue against the ultrasonic blade. The electrode is operable to apply radiofrequency (RF) electrosurgical energy to tissue. The sensor is operable to sense a condition of tissue contacted by the end effector. The control module is operable to control delivery of ultrasonic power and RF electrosurgical energy through the end effector based on data from the sensor.

Claims (42)

1. A surgical instrument, comprising:

(a) a shaft assembly including an acoustic waveguide, wherein the acoustic waveguide is configured to acoustically couple with an ultrasonic transducer;

(b) a control module having a control logic with a first predetermined tissue condition level and a second predetermined tissue level residing thereon, wherein the control logic is configured to receive a first condition of a tissue and determine when the first condition has reached the first and second predetermined tissue condition levels; and

(c) an end effector, including:

(i) an ultrasonic blade in acoustic communication with the acoustic waveguide,

(ii) a clamp arm movably mounted relative to the ultrasonic blade and configured to compress a tissue against the ultrasonic blade, and

(iii) a first electrode configured to receive a radiofrequency (RF) electrosurgical energy via the control module for applying the RF electrosurgical energy to the tissue, wherein the first electrode is further configured to sense the first condition of the tissue contacted by the end effector and communicate the first condition of the tissue to the control module,

wherein the control module is configured to receive the first condition from the first electrode and, after determining that the first condition from the first electrode has reached the first predetermined tissue condition level, automatically activate the end effector to apply ultrasonic energy to the tissue captured between the clamp arm and the ultrasonic blade simultaneously with the RF electrosurgical energy.

2. The surgical instrument of claim 1 , wherein the first electrode includes a positive temperature coefficient (PTC) thermistor.

3. The surgical instrument of claim 2 , wherein the first electrode defines an electrical resistance configured to increase as a temperature of the tissue contacted by the end effector increases.

4. The surgical instrument of claim 1 , further comprising a second electrode configured to receive the RF electrosurgical energy via the control module for applying RF electrosurgical energy to the tissue, and wherein the second electrode is configured to sense a second condition of the tissue contacted by the end effector and communicate the second condition of the tissue to the control module.

5. The surgical instrument of claim 4 , wherein the control module is configured to measure an electrical resistance value between the first electrode and the second electrode through the tissue contacted by the end effector.

6. The surgical instrument of claim 4 , wherein the second electrode includes a positive temperature coefficient (PTC) thermistor.

7. The surgical instrument of claim 1 , wherein the first electrode is integrated into the clamp arm.

8. The surgical instrument of claim 1 , wherein the RF electrosurgical energy is a bipolar RF electrosurgical energy, and wherein the first electrode and the ultrasonic blade are configured to cooperate to apply the bipolar RF electrosurgical energy to the tissue.

9. The surgical instrument of claim 1 , wherein the control module is configured to automatically control delivery of ultrasonic energy and RF electrosurgical energy through the end effector based on the first condition sensed at the first electrode.

10. The surgical instrument of claim 1 , wherein

prior to determining that the first condition from the first electrode has reached the first predetermined condition level on the control module, the control module is configured to automatically activate the end effector to apply only RF electrosurgical energy to the tissue captured between the clamp arm and the ultrasonic blade.

11. The surgical instrument of claim 1 , wherein the control module is configured to modulate between applying ultrasonic energy and RF electrosurgical energy to provide a substantially constant temperature to the tissue.

12. The surgical instrument of claim 1 , further including a sensor configured to sense a second condition of the tissue contacted by the end effector.

13. The surgical instrument of claim 12 , wherein the sensor comprises an impedance sensor.

14. The surgical instrument of claim 1 , further comprising a trigger operatively connected to the control module, wherein the trigger is configured to be selectively actuated, and wherein the control module is configured to initiate activation of the end effector upon selective actuation thereof.

15. The surgical instrument of claim 1 , wherein after determining that the first condition from the first electrode has reached the second predetermined condition level on the control module, the control module is configured to automatically activate the end effector to apply only ultrasonic energy to the tissue captured between the clamp arm and the ultrasonic blade.

16. A surgical instrument, comprising:

(a) a shaft assembly including an acoustic waveguide, wherein the acoustic waveguide is configured to acoustically couple with an ultrasonic transducer;

(b) an end effector, including:

(i) an ultrasonic blade in acoustic communication with the acoustic waveguide,

(ii) a clamp arm movably mounted relative to the ultrasonic blade and configured to compress a tissue against the ultrasonic blade, and

(iii) a first electrode configured to apply a radiofrequency (RF) electrosurgical energy to the tissue, wherein the first electrode is configured to monitor a first temperature of tissue contacted by the end effector; and

(c) a control module operatively connected to the first electrode and having a control logic with a first predetermined temperature level residing thereon, wherein the control module is operatively connected to the first electrode such that the control logic is configured to receive the first temperature of the tissue and determine when the first temperature has reached the first predetermined temperature level to thereby automatically activate the end effector to apply ultrasonic energy to the tissue captured between the clamp arm and the ultrasonic blade simultaneously with the RF electrosurgical energy.

17. The surgical instrument of claim 16 , wherein the first electrode includes a positive temperature coefficient (PTC) thermistor.

18. The surgical instrument of claim 16 , further comprising a second electrode configured to apply the RF electrosurgical energy to the tissue, wherein the second electrode is configured to sense a second temperature of the tissue contacted by the end effector.

19. The surgical instrument of claim 18 , wherein the control module is operatively connected to the second electrode such that the control logic is configured to receive the second temperature of the tissue, and wherein the control module is configured to measure an electrical resistance value between the first electrode and the second electrode through the tissue contacted by the end effector.

20. A surgical instrument, comprising:

(a) a shaft assembly including an acoustic waveguide, wherein the acoustic waveguide is configured to acoustically couple with an ultrasonic transducer;

(b) an end effector, including:

(i) an ultrasonic blade in acoustic communication with the acoustic waveguide,

(ii) a clamp arm movably mounted relative to the ultrasonic blade and configured to compress a tissue against the ultrasonic blade, and

(iii) a first electrode configured to apply a radiofrequency (RF) electrosurgical energy to the tissue, wherein the first electrode is configured to sense a first temperature of tissue contacted by the end effector; and

(c) a control module operatively connected to the first electrode and having a control logic with first and second predetermined temperature levels residing thereon, wherein the control module is operatively connected to the first electrode such that the control logic is configured to receive the first temperature of the tissue from the first electrode, wherein the control module is configured to:

(i) activate the end effector to apply ultrasonic energy to the tissue captured between the clamp arm and the ultrasonic blade simultaneously with the RF electrosurgical energy when the first temperature of the tissue increases to the first predetermined temperature level; and

(ii) activate the end effector to apply only ultrasonic energy to the tissue captured between the clamp arm and the ultrasonic blade when the first temperature of the tissue increases to the second predetermined temperature level.

Assignments (1)
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Apr 27, 2021
From: ETHICON LLC
To: CILAG GMBH INTERNATIONAL
Reel/Frame 056601/0339 →
Cited By (1)
US 12,251,124